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     INTRODUCTION 
  Dengue is an endemic, mosquito-borne viral disease 
throughout the tropics. Over 50 million dengue virus (DENV) 
infections are estimated to occur annually,  1   and this number 
is projected to increase.  2   Treatment is supportive with fluid 
replacement for plasma leakage, detected through regular 
monitoring for rising hematocrit levels, being the key fea-
ture.  3   Although early diagnosis is useful in triaging patients, 
it could have a central role in dengue case management at a 
future time when antiviral drugs for dengue—the subject of 
intense research interest—become available for clinical use. 
In particular, immediate bedside diagnosis would be preferred 
to laboratory diagnosis, because the window of opportunity 
for antiviral therapy in dengue may be limited because of the 
short-lived viremia.  4  
  The 1997 World Health Organization (WHO) dengue case 
definition  5   has defined standards for diagnosis, clinical man-
agement, and reporting. Its main thrust was to enable disease 
classification for case management based on the presence of 
specific symptoms and signs. However, with the reemergence 
and global expansion of dengue, infection in adults has become 
increasingly common, and studies have found that the 1997 
classification fails to detect a significant proportion of severe 
dengue cases in adults compared with children.  6–  8  These  obser-
vations led to a revision of the WHO dengue case classifica-
tion published in 2009.  9   Although attention has been focused 
on the utility of these classification schemes in patient man-
agement,  6–  8   whether they can also be applied for early dengue 
diagnosis has not been evaluated, especially in adults.  10  
  The recent availability of a rapid dipstick test, the Dengue 
NS1 Ag Strip (Bio-Rad Laboratories, Marnes-la-Coquette, 
France      ), that can provide results within 15 minutes could serve 
as a useful bedside diagnostic tool. NS1 is a highly conserved 
non-structural glycoprotein secreted by virus-infected cells 
during the acute phase of dengue,  11,  12  and it is essential for virus 
viability.  13   However, it is not known how this test performs rel-
ative to the 1997 or 2009 WHO classification schemes. 
  Thus, the primary objective of this study was to compare the 
sensitivity and specificity of the NS1 strip with the 1997 and 
2009 WHO classification schemes for the diagnosis of acute 
dengue fever. The secondary objectives were to evaluate the 
sensitivity of the tests in primary compared with secondary 
dengue infection, virus serotype, and clinical characteristics 
observed in the early stages of dengue illness. 
   MATERIALS AND  METHODS 
  Serum  samples.     The Dengue NS1 Ag Strip was evaluated on 
archived serum samples collected from patients prospectively 
enrolled in the early dengue infection and outcome (EDEN) 
study.  14   The EDEN study was approved by the National 
Healthcare Group Institutional Review Board (IRB)       (DSRB 
B/05/013). Adult patients (18 years and above) presenting to 
various community polyclinics in Singapore within 72 hours 
of acute febrile illness (≥ 37.5°C) were enrolled with informed 
consent (first visit). Sera collected were tested for dengue virus 
using reverse transcription polymerase chain reaction (RT-PCR), 
virus isolation, and serology. A complete blood count was also 
performed on anticoagulated blood collected from all patients. 
The remaining serum was aliquoted and stored at −80°C until 
use. Sera were also collected from study participants at days 
4–7 (second visit) and weeks 3–4 (third visit) after fever onset. 
Sera collected at the two later time points were also tested for 
DENV immunoglobulin M (IgM) and IgG antibodies. 
  A total of 1,811 patients have been enrolled to date in the 
EDEN study. Convenience sampling of the archived sera from 
dengue RT-PCR and/or virus isolation positive and negative 
was carried out. Altogether, sera from 354 patients were used 
in this study. 
  RT-PCR.     Viral RNAs were extracted using the QIAamp 
Viral RNA mini kit (Qiagen, Germany), and real-time 
RT-PCR was carried out using a set of primers targeting the 
3′ non-coding region of dengue viruses.  15   LightCycler software 
version 3.5 was used to analyze results. Positive control using 
RNA from the four DENV serotypes cultured in the   Aedes 
albopictus   mosquito (C6/36) cell line and water-only negative 
control were included in every RT-PCR run. 
   Virus  isolation.    The  C6/36  cell  line     (American  Type 
Culture Collection [ATCC]: CRL-1660) was used for virus 
isolation. DENV antigens were detected using indirect 
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immunofluorescence assay in conjunction with flavivirus, 
DENV group-specific, and DENV serotype-specific monoclonal 
antibodies from clarified hybridoma culture supernatant 
(ATCC: HB-46, -47, -48, -49, 112, and -114)  16,  17   and fluorescein 
isothiocyanate-conjugated goat anti-mouse antibody. 
   Serology.     Serum was tested for anti-DENV IgM and IgG 
antibodies using an IgM capture and indirect enzyme-linked 
immunosorbent assays (ELISAs), respectively (Panbio, 
Australia), according to the manufacturer’s instructions. 
    WHO  dengue  classification  schemes.     Clinical data obtained 
from EDEN patients within 72 hours of fever onset were 
used in a diagnosis of probable dengue versus other febrile 
illness using the 1997 and 2009 WHO classification schemes. 
The 1997 WHO classification  5   classifies acute febrile illness as 
dengue fever based on headache, retro-orbital pain, myalgia, 
arthralgia, rash, hemorrhagic manifestations, and leukopenia. 
In contrast, the 2009 WHO classification  9   uses two or more 
clinical manifestations for probable dengue classification: 
nausea/vomiting, rash, aches and pains, tourniquet test posi-
tive, leucopenia, and any warning signs. For this analysis, 
leukopenia was defined as white blood cell (WBC) count 
below 4.5 × 10  3 / μL, and arthralgia/myalgia was included under 
aches and pains. Information on tourniquet test positivity was 
not obtained and hence, was not included in this analysis. 
  Because the goal of this study was to evaluate the perfor-
mance of the dengue classification schemes as tools for early 
diagnosis, we have not included five of seven warning signs 
listed in the 2009 classification  9   as criteria for diagnosis. These 
signs, namely clinical fluid accumulation, liver enlargement 
(> 2 cm), increase in hematocrit, persistent vomiting, and leth-
argy/restlessness, were present in some cases but at either the 
second visit or later, and they were detected through repeated 
monitoring. Hence, they may not be useful for early dengue 
diagnosis. Abdominal pain and mucosal bleeding were the 
only warning signs included in our diagnostic analysis. 
      Immunochromatographic detection of dengue NS1 antigen.  
  The Dengue NS1 Ag Strip is a lateral flow immunochro-
matography test for the detection of the NS1 antigen. The 
manufacturer recommended that the NS1 Strip be read at 
15 minutes and again at 30 minutes for doubtful samples or 
negative samples in patients with suggestive clinical informa-
tion. In this study, the test was read at both 15 and 30 minutes 
for all serum samples, and the results were analyzed separately. 
Two technicians read each NS1 strip independently and 
were blinded to the infection status of the serum sample. If 
interpretations were conflicting, the final result was taken as 
equivocal. 
   Statistics.     Statistical analysis was performed with SAS 
software, version 9.2. The two-sample   t   test was used to 
analyze continuous variables, and Fisher’s exact test was used 
to compare binary variables and sensitivity. 
    RESULTS 
  Baseline demographic, clinical, and laboratory findings of 
the study populations are summarized in   Table 1  . Of the 354 
sera, 153 were dengue positive by RT-PCR and virus isola-
tion, and 1 serum sample was dengue positive by virus iso-
lation alone. The 200 RT-PCR and virus isolation negative 
samples were also negative for antidengue IgM antibodies 
in the corresponding convalescent sera. These were classified 
as other febrile illness (OFI) for subsequent analyses. There 
was a slight male predominance in both dengue positive cases 
and other febrile illnesses, which is consistent with previous 
epidemiological observations in Singapore.  18   Dengue  posi-
tive patients were older than those with OFIs (39.4 versus 
36.6 years, respectively;   P   = 0.040). Patients with OFIs sought 
medical care slightly earlier than patients with dengue 
(1.8 versus 2.1      , respectively;   P   < 0.001). The WBC and plate-
let counts per microliter blood were significantly lower at first 
visit (baseline) for dengue cases than for OFIs (  P   < 0.001). 
      When  the  1997  WHO  dengue  classification  scheme  was 
applied to the 354 total cases, 147 of 154 (95.4%) dengue cases 
and 128 (64.0%) of 200 OFI cases were diagnosed as dengue 
fever. Hence, the 1997 WHO classification scheme’s sensitivity 
and specificity for dengue were 95.4% and 36.0%, respectively 
(  Table 2  ). The 2009 WHO classification scheme identified 123 
(79.9%) of dengue and 86 (43.0%) of OFI cases as probable 
dengue, giving sensitivity and specificity of 79.9% and 57.0%, 
respectively (  Table 2  ). The NS1 strip had a sensitivity and 
specificity of 77.3% and 100%, respectively, at 15 minutes, and 
80.5% and 100%, respectively, at 30 minutes (  Table 2  ). 
 Table 1 
    Baseline demographic, hematological, clinical, and virological infor-
mation of the study population   
Dengue (  N   = 154) OFI (  N   = 200)   P   value * 
Demographics
  Male gender (%) 89 (57.8) 121 (60.5) 0.700
  Age in years (SD) 39.4 (13.4) 36.6 (13.2) 0.040
  Chinese ethnicity (%)  †  119 (77.3) 133 (66.5) 0.030
Days from illness onset at 
enrollment (SD) 2.1 (0.8) 1.8 (0.8) < 0.001
Clinical presentation
  Headache (%) 126 (81.8) 132 (66.0) 0.001
  Retro-orbital pain (%) 41 (26.6) 27 (13.5) 0.003
  Myalgia (%) 106 (68.8) 123 (61.5) 0.200
  Arthralgia (%) 96 (62.3) 107 (53.5) 0.100
  Rash (%) 16 (10.4) 6 (3.0) 0.007
  Nausea (%) 79 (51.3) 61 (30.5) < 0.001
  Vomiting (%) 25 (16.2) 17 (8.5) 0.030
  Mucosal bleed (%) 11 (7.1) 6 (3.0) 0.080
  Abdominal pain (%) 12 (7.8) 43 (21.5) < 0.001
 Leukopenia  < 4.5 × 10  3 / μL (%) 111 (72.1) 23 (11.5) < 0.001
Thrombocytopenia 
< 100 × 10  3 / μL (%) 23 (14.9) 3 (1.5) < 0.001
DENV serotype
  DENV-1 (%) 54 (35.1)
  DENV-2 (%) 46 (29.9)
  DENV-3 (%) 54 (35.1)
 DENV-4  (%) 0
Serological status
  Primary infection (%) 75 (48.7)
  Secondary infection (%) 79 (51.3)
  *   Continuous  variables,   t   test; categorical variables, Fisher’s exact test.   
    †     Other ethnic groups in the study population were Malays, Indians, and Caucasians.   
 Table 2 
    Sensitivity and specificity of the Dengue NS1 Ag Strip test and 1997 
and 2009 WHO classification schemes relative to RT-PCR and virus 
isolation  
Diagnostic modality Sensitivity (95% CI)  *  Specificity (95% CI)  † 
Dengue NS1 Strip 15 minutes 77.3% (69.8–83.6) 100% (98.5)  ‡ 
Dengue NS1 Strip 30 minutes 80.5% (73.5–86.5) 100% (98.5)  ‡ 
WHO 1997 95.4% (90.9–98.2) 36.0% (29.4–43.1)
WHO 2009 79.9% (72.7–85.9) 57.0% (49.8–64.0)
  *     N   = 154.   
  †     N   = 200.   
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            The comparative performance of the NS1 strip and 1997 
and 2009 WHO classification schemes was statistically ana-
lyzed for dengue cases relative to presence or absence of pre-
existing antidengue antibodies (IgG+/IgG−), DENV serotype 
(DENV-1, -2, or -3), and time from illness onset (day 1, 2, or 3). 
Clinical outcome in terms of hospitalization was also investi-
gated. The data and analysis are summarized in   Table 3  . The 
WHO 1997 classification scheme identified most of the den-
gue cases in all categories analyzed. Statistically significant 
differences in sensitivity were observed between IgG+ and 
IgG− patients for the NS1 strip (  P   < 0.001) and the WHO 1997 
classification scheme (  P   = 0.014) (  Table 3  ). 
      When  comparing  the  performance  of  the  diagnostic 
approaches in primary and secondary infection, we took a 
positive finding on an antidengue IgG ELISA in the acute 
serum sample as indicative of secondary infection. Although 
antibodies to Japanese encephalitis virus (JEV; another flavi-
virus endemic in Southeast Asia) can cross-react with ELISA, 
Singapore has a very low seroprevalence of JEV.  19    Table  3  
shows that, consistent with previous observations, the NS1 
strip had significantly higher sensitivity for primary infections 
(94.7%) than for secondary infections (67.1%;   P   < 0.001).  20,  21  
The 1997 WHO classification had higher sensitivity for pri-
mary dengue (100%) than for secondary dengue (91.1%), and 
this difference was also statistically significant (  P   = 0.014). The 
2009 WHO classification also had higher sensitivity for pri-
mary dengue (84.0%) than for secondary dengue (75.9%), but 
this difference was not statistically significant. 
  The sensitivity of the NS1 strip was lower in patients 
enrolled on day 1 of fever than those enrolled on days 2 and 3 
(  Table 3  ), and statistically significant differences in sensitivity 
were observed at 30 minutes ( P  = 0.010). However, the propor-
tion of patients presenting with acute primary infection was 
lower on day 1 (35.9%, 14/39) compared with day 2 (60.3%, 
35/58) and day 3 (45.6%, 26/57). On evaluating those with pri-
mary infections alone, no statistically significant difference 
was observed in the sensitivity of the NS1 strip for the first 3 
days of febrile illness (at 30 minutes;   P   = 1.000). For secondary 
infections alone, there was an increase in sensitivity between 
sera collected on day 1 (44.0%) and that collected on day 3 
(83.9%), and there were statistically significant differences at 
30 minutes (day 1 versus day 3;   P   = 0.004). An increase in sen-
sitivity of the 2009 WHO classification was also observed for 
patients who presented on day 3 (89.5%) compared with those 
who presented on day 1 (61.5%;   P   = 0.004) (  Table 3  ). 
  No statistically significant differences were found in the 
sensitivity of the three diagnostic approaches in patients with 
different DENV serotypes (  Table 3  ). A statistically signifi-
cant difference was found for the 2009 WHO classification for 
patients who eventually received hospitalized care (86.0%) 
versus patients who were not hospitalized (72.1%;   P   = 0.043). 
No significant differences were found using the NS1 strip and 
the WHO 1997 classification scheme with regards to eventual 
hospitalization. 
   DISCUSSION 
  Medical centers in many dengue endemic regions lack ready 
access to a diagnostic laboratory that would enable early diag-
nosis of dengue. This lack of diagnostic resources portends an 
important rate-limiting obstacle in the proper usage of anti-
viral drugs after they become available. We have, therefore, 
focused this study on diagnostic approaches that can be car-
ried out by the attending clinician without diagnostic labora-
tory support. 
  The performances of the WHO 1997 and 2009 classifica-
tion schemes and the NS1 strip test were evaluated in serum 
samples that tested positive or negative using real-time 
RT-PCR and virus isolation for DENV. The highest sensitiv-
ity was observed in the 1997 classification (95.4%) followed 
by the NS1 strip (80.5%) and 2009 classification (79.9%). 
Conversely, specificity was highest in the NS1 strip (100%) 
followed by the 2009 and 1997 classifications (57.0% and 
36.0%, respectively). 
  Although previous studies have described the clinical fea-
tures that could potentially differentiate dengue from other 
acute febrile illnesses,  10,  22–  24   these have not used the 1997 and 
2009 classification schemes that are based primarily on a set 
of defined clinical symptoms and signs. Our findings suggest 
that the 1997 classification, with a sensitivity of 95.4%, could 
be very useful in ruling out dengue in the early febrile phase 
of illness, but confirmatory diagnosis cannot be achieved given 
the poor specificity. 
  An obvious solution to dengue diagnosis is, thus, to use the 
1997 classification scheme to rule out dengue and to use a 
bedside diagnostic test such as the NS1 strip to confirm the 
diagnosis. However, the performance of the latter has some 
important limitations. Compared with primary infections, 
the NS1 strip has lower sensitivity for secondary infections 
where pre-existing NS1 antibodies in the serum could inhibit 
the detection of NS1 antigen.  20,  21,  25–  27   Hence, for patient pop-
ulations in dengue hyperendemic countries where multiple 
DENV serotypes cocirculate, the NS1 strip might not be ade-
quate for bedside confirmation of dengue diagnosis. 
  An important question is whether the different approaches to 
dengue diagnosis would miss those that eventually developed 
 Table 3 
    The performance of the NS1 strip and 1997 and 2009 WHO classifica-
tion schemes in secondary DENV infection, infection with differ-
ent DENV serotypes, time of clinical presentation, and outcome in 
terms of hospitalization   
Variable
Total dengue 
(%) * 
Number (%) testing positive
NS1 
(  N   = 124)
WHO 1997 
(  N   = 147)
WHO 2009 
(  N   = 123)
Serological status at first visit
IgG+ (secondary 
infection) 79 (51.3) 53 (67.1) 72 (91.1) 60 (75.9)
IgG— (primary 
infection) 75 (48.7) 71 (94.7) 75 (100) 63 (84.0)
   P    value †  < 0.001 0.014 0.234
DENV serotype
  DENV-1 54 (35.1) 43 (79.6) 53 (98.1) 44 (81.5)
  DENV-2 46 (29.9) 34 (73.9) 43 (93.5) 35 (76.1)
  DENV-3 54 (35.1) 47 (87.0) 51 (94.4) 44 (81.5)
   P    value †  0.256 0.508 0.793
Day of fever
  1 39 (25.3) 25 (64.1) 36 (92.3) 24 (61.5)
  2 58 (37.7) 48 (82.8) 56 (96.6) 48 (82.8)
  3 57 (37.0) 51 (89.5) 55 (96.5) 51 (89.5)
   P    value †  0.010 ‡  0.551 0.004 § 
Clinical outcome
  Hospitalized 86 (55.8) 73 (84.9) 82 (95.3) 74 (86.0)
  Not hospitalized 68 (44.2) 51 (75.0) 65 (95.6) 49 (72.1)
   P    value †  0.153 1.000 0.043
  *     N   = 154.   
  †   Fisher’s  exact  test.  
  ‡   Day  1  vs.  2,   P   = 0.054; day 1 vs. 3,   P   = 0.004; day 2 vs. 3,   P   = 0.420.   
  §   Day  1  vs.  2,   P   = 0.032; day 1 vs. 3,   P   = 0.002; day 2 vs. 3,   P   = 0.420.   227 EARLY DENGUE DIAGNOSIS
severe disease. In the 2009 classification, severe dengue disease 
includes those with plasma leakage, internal hemorrhage, or 
severe organ impairment. Unfortunately, the number of cases 
that presented with these clinical outcomes was small, and a 
meaningful analysis could not be conducted. We have instead 
tested for differences in hospitalization rate among those 
identified as dengue using different diagnostic approaches 
and have found a statistically significant difference only for 
the 2009 WHO classification scheme. 
  The NS1 strip also seemed to be less sensitive when used 
in patients within the first day from illness onset. In our col-
lection of samples, a substantial proportion of patients with 
secondary dengue infection (DENV IgG positive) presented 
on the first day of fever for reasons yet to be determined. 
This resulted in reduced sensitivity of the NS1 strip on day 1 
compared with days 2 and 3 of illness. On evaluating the 
sensitivity of the NS1 strip for primary and secondary infec-
tions versus day of illness, the findings of this study agree 
with another report,  27   which found an increase in sensitiv-
ity of the NS1 strip for secondary infections between days 
0 and 3. 
  Reports on the sensitivity of the NS1 strip for the four den-
gue virus serotypes have varied depending on the geographical 
region of testing. Earlier reports found no significant differ-
ence in sensitivity of the NS1 strip for different serotypes  27 ; 
however, recent studies from Vietnam  21   and  Venezuela 25  
have found that the sensitivity of the NS1 strip was lower for 
DENV-2 infections. A possible explanation for this finding is 
that a clinically overt DENV-2 infection is more likely to occur 
in the context of secondary infection than primary infection 
and hence, the associated reduction in sensitivity of the NS1 
strip.  21   In this study, no statistically significant differences were 
observed between the serotypes when divided into primary or 
secondary infections. 
  The strength of this case-control study is the use of serum 
obtained from prospectively enrolled cases with standard-
ized collection of clinical information. Laboratory tests 
were used to confirm the presence or absence of acute den-
gue infection in both cases and controls. All the patients 
presented with acute febrile illness within the first 72 hours 
from fever onset. This period represents the viremic phase 
and is relevant to eventual antiviral applications. The main 
limitation of this study is that, for the 2009 classification, 
not all warning signs could be included for analysis. A tour-
niquet test was not carried out.  14   However, the results of 
this test in making diagnoses are mixed  7,  22   and would not be 
expected to substantially alter our findings. Interpretation 
of what constitutes persistent vomiting and lethargy/rest-
lessness proved difficult from our clinical data obtained 
through a standardized questionnaire, and we have, thus, 
not included these for analysis. This study is also limited to 
adult patients, and the sensitivity and specificity of the WHO 
classification schemes may differ in younger age groups.  28  
Furthermore, the majority of our population was of Chinese 
ethnicity, and the performance of the NS1 could differ in dif-
ferent races or in viruses circulating in different regions of 
the world.  29  
  In conclusion, the 1997 WHO dengue case definition can be 
useful in ruling out dengue, whereas the Dengue NS1 Ag Strip 
can be used as a bedside diagnostic test to support a diagnosis 
of acute dengue, although caution is advised in the interpreta-
tion of this test in dengue hyperendemic areas. 
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